Toll Free: 1-888-928-9744

Wellstat Therapeutics Corporation - Product Pipeline Review - 2014

Published: May, 2014 | Pages: 24 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Wellstat Therapeutics Corporation - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Wellstat Therapeutics Corporation - Product Pipeline Review - 2014', provides an overview of the Wellstat Therapeutics Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Wellstat Therapeutics Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Wellstat Therapeutics Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Wellstat Therapeutics Corporation's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Wellstat Therapeutics Corporation's pipeline products

Reasons to buy

- Evaluate Wellstat Therapeutics Corporation's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Wellstat Therapeutics Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Wellstat Therapeutics Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Wellstat Therapeutics Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Wellstat Therapeutics Corporation
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Wellstat Therapeutics Corporation and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Wellstat Therapeutics Corporation Snapshot 4
Wellstat Therapeutics Corporation Overview 4
Key Information 4
Key Facts 4
Wellstat Therapeutics Corporation - Research and Development Overview 5
Key Therapeutic Areas 5
Wellstat Therapeutics Corporation - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Wellstat Therapeutics Corporation - Pipeline Products Glance 9
Wellstat Therapeutics Corporation - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Wellstat Therapeutics Corporation - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Wellstat Therapeutics Corporation - Drug Profiles 11
uridine triacetate 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
PN-2XXX 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
PN-951 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
PN-XXXX 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Wellstat Therapeutics Corporation - Pipeline Analysis 16
Wellstat Therapeutics Corporation - Pipeline Products by Target 16
Wellstat Therapeutics Corporation - Pipeline Products by Route of Administration 17
Wellstat Therapeutics Corporation - Pipeline Products by Molecule Type 18
Wellstat Therapeutics Corporation - Pipeline Products by Mechanism of Action 19
Wellstat Therapeutics Corporation - Recent Pipeline Updates 20
Wellstat Therapeutics Corporation - Dormant Projects 21
Wellstat Therapeutics Corporation - Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24
List of Tables
Wellstat Therapeutics Corporation, Key Information 4
Wellstat Therapeutics Corporation, Key Facts 4
Wellstat Therapeutics Corporation - Pipeline by Indication, 2014 6
Wellstat Therapeutics Corporation - Pipeline by Stage of Development, 2014 7
Wellstat Therapeutics Corporation - Monotherapy Products in Pipeline, 2014 8
Wellstat Therapeutics Corporation - Phase II, 2014 9
Wellstat Therapeutics Corporation - Preclinical, 2014 10
Wellstat Therapeutics Corporation - Pipeline by Target, 2014 16
Wellstat Therapeutics Corporation - Pipeline by Route of Administration, 2014 17
Wellstat Therapeutics Corporation - Pipeline by Molecule Type, 2014 18
Wellstat Therapeutics Corporation - Pipeline Products by Mechanism of Action, 2014 19
Wellstat Therapeutics Corporation - Recent Pipeline Updates, 2014 20
Wellstat Therapeutics Corporation - Dormant Developmental Projects,2014 21 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify